Mankind Pharma To Acquire 70% Stake In Cancer Therapy Firm ACTx, ₹511 Crore Deal Marks Entry Into Advanced Cancer Treatments

Mumbai: Mankind Pharma has announced a major investment in advanced cancer treatment by agreeing to acquire a 70 per cent stake in Belgium-based Armed Cell Therapeutics B.V. (ACTx) for €48 million, or approximately Rs 511.18 crore.The acquisition marks Mankind Pharma’s entry into next-generation cancer cell therapies and strengthens its plans to expand into innovative healthcare treatments.Rs 511 Crore Deal Through...